Back to search

National and Kapodistrian University of Athens

Πολυμορφία του β3 αδρενεργικού υποδοχέα (β3AR) σε ασθενείς με γενικευμένη αρτηριοπάθεια και ινσουλινοαντοχή: σχέση με τον τύπο της παχυσαρκίας

Abstract

dc:description

Atherosclerosis is a process that starts early in life, possibly already during thefirst years of life. It is the result of the added effect of multiple risk factors,hereditary, behavioral and environmental. We studied the effect of several featuresof the metabolic syndrome on coronary artery disease (CAD) and peripheralangiopathy in a cohort of patients (n=224) undergoing coronary angiography: westudied the effect of obesity, of metabolic parameters and of certain related geneticpolymorphisms. We studied the β3 AR genetic polymorphism (β3ΑR - Τrp64Arg)which participates in energy expenditure and appears to be related to obesity andfeatures of the metabolic syndrome. We further studied the PPRγ (Pro12Ala)polymorphism as this receptor connects the adipose tissue with insulin resistance(ΙR). The latter has been reported to act synergistically with the β3AR polymophism.Finally, in a subgroup of 105 patients, the morning levels and diurnal rhythm ofcortisol were determined, and the sensitivity of the HPA (hypothalamic pituitaryadrenal) axis was assessed with relation to the severity of CAD and peripheralarterial disease. In this subgroup a common polymorphism of the glucocorticoidreceptor was studied (GR Bcl1), as this has been associated with increased sensitivityto glucocorticoids and features of the metabolic syndrome.We found a significant positive correlation of the severity of CAD with theWHR and not with BMI which was independent of age and gendre. WHR hadsignificant positive correlation with uric acid, triglyceride and VLDL cholesterollevels and negative with HDL and apoA. HOMA index of insulin resistance hadsignificant correlation with CAD severity and femoral artery IMT. It thus appearsthat in our population the severity of CAD is influenced by the type rather than thedegree of obesity, while peripheral angiopathy is not influenced by obesity itself.These results indicate that metabolic parameters and predisposing genetic factorsprobably involved in the appearance of the metabolic syndrome collaborate in thedevelopment of CAD. It is interesting that in our study too we found that insulinresistance is associated with both CAD and peripheral angiopathy, apparentlybecause it reflects mechanisms that have been repeatedly recognised as aggravatingfor the arteries. The prevalence of the β3AR was 8.8%. There were no differences concerningCAD or peripheral angiopathy according to the presence of the polymorphism.Trp64Arg β3AR carriers had higher cholesterol LDL cholesterol and apoB levels.Contrary to some reports in the literature we did not find any differences in IR,arterial blood pressure or clinical measures of adiposity. Therefore thispolymorphism was not found to play a role in obesity parameters, angiopathy orCAD severity. It can be speculated that this genetic polymorphism may have someindirect effect on the vessels through its influence on lipid parameters.Another polymorphism that might have some influence on IR and indirectly onthe metabolic syndrome is the Pro12Ala PPARγ gene polymorphism. Personscarrying this polymorphism had a reduced tendency to have IR. Furthermore, carriershad less frequently DM2, a finding supporting the protective role of PPARγ for theappearance of DM2. Another interesting finding was the protective role of this allelefor the presence of hypertension.Pro12Ala carriers did not differ as to presence and extent of CAD, nor in obesityparameters. Finally the carotid artery IMT was shorter in carriers, independently oflipid levels. Therefore, in this population with multiple predisposing factors, even theheterozygous presence of the mutation had a protective effect on peripheral arterialdisease; furthermore it has a protective factor for DM2 and arterial hypertension,confirming previous reports in the literature.The coexistence of the two polymorphism was associated with highercholesterol, LDL cholesterol and apoA levels compared to those who had one ornone of the two polymorphisms. No difference in the other metabolic parameters inthe 4 haplotypes were found, which shows that the coexistence of thesepolymorphisms do not associate with more severe CAD or arterial disease. It onlyassociates with lipid levels and in this way might indirectly have a mild effect.Finally, a significant finding of our study was the correlation of the severity ofCAD with basal cortisol levels in the morning before the angiography wasperformed. This association was independent of other predisposing factors, age andgendre. There was also a tendency for a similar correlation with peripheral arterialdisease in the femoral artery. In the small subgroup where sensitivity toglucocorticoids was assessed with the ultra-low-dose dexamethazone test, we also assessed the presence of the Bcl1 GR polymorphism. GG homozygotes had a highercortisol between morning evening measurements and higher cortisol suppressionafter dexamethazone. They also had a higher WH ratio and higher IMT in theircarotid artery, however none of these differences was significant although they allwere in the same direction. No differences in severity of CAD according to GRgenotype was observed; however one has to note that the number of subjectsgenotyped was small.According to these results, we suggest that basal cortisol levels could constitutean independent predictor of the severity of CAD in subjects showing hyperactivity ofthe HPA axis at the moment of anticipation of severe stress (such as the oneexperienced before a coronary angiography). It is likely that in these subjects theelevated cortisols reflect the chronic response to stress. The association of the GRpolymorphism with peripheral arterial disease indicates that the sensitivity toglucocorticoids may contribute to more severe atherosclerosis.On the basis of these findings one could argue that both the hyperactive HPAaxis as well as the sensitivity to glucocorticoids may independently contribute to theseverity of CAD and peripheral atherosclerosis. It may be that the consequences onthe arteries may be worse when these factors coexist.In conclusion, our study has shown that the type of obesity is more importantthan the degree of obesity as a predictor of the severity of CAD. From the geneticfactors examined that might be involved, the polymorphism of the β3AR was foundto have a marginal significance only for lipids, while the role of the PPARγ appearsto be important for various parameters of the metabolic syndrome and is alsoimportant for vascular health. Finally a clear association of the activatedglucocorticoid axis with the severity of CAD was identified.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Cimponeriu, Adriana-Emilia
  • Τσιμπονέριου, Αντριάνα-Αιμιλία

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29742

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Cimponeriu, Adriana-Emilia; Τσιμπονέριου, Αντριάνα-Αιμιλία. Πολυμορφία του β3 αδρενεργικού υποδοχέα (β3AR) σε ασθενείς με γενικευμένη αρτηριοπάθεια και ινσουλινοαντοχή: σχέση με τον τύπο της παχυσαρκίας. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/29742